Aehr Test Systems, Inc. (AEHR)

NASDAQ: AEHR · Real-Time Price · USD

93.81

-1.75 (-1.83%)

At close: Sep 10, 2026, 4:00 PM EDT

92.37

-1.44 (-1.54%)

After-hours: Sep 10, 2026, 7:59 PM EDT

Aehr Test Systems Income Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 29, 2026	May '25 May 30, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Revenue	50	58.97	66.22	64.96	50.83
Revenue Growth	-15.21%	-10.95%	1.93%	27.80%	206.20%
Cost of Revenue	32.35	35.04	33.68	32.22	27.16
Gross Profit	17.65	23.93	32.54	32.75	23.67
Selling, General & Admin	19.16	17.78	13.75	12.24	10.05
Research & Development	12.63	10.46	8.72	7.13	5.82
Operating Expenses	31.79	28.25	22.47	19.37	15.87
Operating Income	-14.14	-4.31	10.08	13.38	7.8
Interest & Investment Income	1.36	1.4	2.39	1.25	0.01
Other Non Operating Income (Expenses)	0.05	-0.02	-0.01	-0	0.03
EBT Excluding Unusual Items	-12.73	-2.93	12.46	14.62	7.84
Merger & Restructuring Charges	-0.01	-1.36	-	-	-
Other Unusual Items	1	-	-	-	1.7
Pretax Income	-11.74	-4.29	12.46	14.62	9.54
Income Tax Expense	-4.61	-0.38	-20.7	0.06	0.09
Net Income	-7.13	-3.91	33.16	14.56	9.45
Net Income to Common	-7.13	-3.91	33.16	14.56	9.45
Net Income Growth	-	-	127.77%	54.04%	-
Shares Outstanding (Basic)	31	30	29	28	26
Shares Outstanding (Diluted)	31	30	30	29	28
Shares Change	3.68%	-0.12%	1.38%	5.19%	18.40%
EPS (Basic)	-0.23	-0.13	1.15	0.52	0.36
EPS (Diluted)	-0.23	-0.13	1.12	0.50	0.34
EPS Growth	-	-	124.00%	47.06%	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 29, 2026	May '25 May 30, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Free Cash Flow	-5.38	-12.39	1.01	8.65	1.09
Free Cash Flow Per Share	-0.17	-0.42	0.03	0.30	0.04
Gross Margin	35.30%	40.59%	49.15%	50.41%	46.56%
Operating Margin	-28.29%	-7.31%	15.22%	20.59%	15.35%
Profit Margin	-14.25%	-6.63%	50.07%	22.41%	18.59%
Free Cash Flow Margin	-10.75%	-21.02%	1.52%	13.31%	2.15%
EBITDA	-11.34	-2	10.74	13.83	8.16
EBITDA Margin	-22.69%	-3.39%	16.21%	21.28%	16.05%
D&A For EBITDA	2.8	2.31	0.66	0.45	0.36
EBIT	-14.14	-4.31	10.08	13.38	7.8
EBIT Margin	-28.29%	-7.31%	15.22%	20.59%	15.35%
Effective Tax Rate	-	-	-	0.41%	0.95%
Revenue as Reported	-	-	-	-	50.83

SEC Filings: 10-K · 10-Q